Layton, J. Bradley http://orcid.org/0000-0003-0994-5820
Forns, Joan http://orcid.org/0000-0002-1066-0358
McQuay, Lisa J. http://orcid.org/0000-0001-8842-9431
Danysh, Heather E. http://orcid.org/0000-0003-3014-7508
Dempsey, Colleen
Anthony, Mary S. http://orcid.org/0000-0002-5760-6965
Turner, Mary Ellen
Funding for this research was provided by:
ACADIA Pharmaceuticals
Article History
Accepted: 22 November 2022
First Online: 14 December 2022
Declarations
:
: This study was conducted by researchers at RTI Health Solutions, an independent nonprofit research organization. Funding for the research was received from Acadia Pharmaceuticals Inc., the manufacturer of pimavanserin. The contract between RTI Health Solutions and Acadia Pharmaceuticals Inc. includes independent publication rights.
: MET and CD are employees of Acadia Pharmaceuticals Inc., the manufacturer of pimavanserin. JBL, JF, HED, LJM, and MSA are employees of RTI Health Solutions.
: The data that support the findings of this study are available from the US Centers for Medicare and Medicaid Services (CMS), but restrictions apply to the availability of these data, which were used under license for the current study and so are not publicly available. The authors are not authorized to release data based on CMS privacy policies. Data are however available with permission from CMS (ExternalRef removed) upon the establishment of a data use agreement.
: This analysis was determined to be exempt from institutional review board (IRB) review by the RTI International (RTI) IRB on December 14, 2020 (RTI IRB Study ID 00021361). The US CMS Privacy Board approved the use of Medicare Research Identifiable Files for this study under a data use agreement with RTI Health Solutions.
: The RTI IRB determined that individual-level consent was not required for this analysis of secondary, deidentified data.
: Not applicable.
: Not applicable.
: JBL and JF contributed to the conceptualization, methodology, visualization, and writing of the original draft. HED contributed to the resources, project administration, and writing for the review and editing drafts of the manuscript. LJM contributed to the methodology, software, formal analysis, data curation, and writing for the review and editing drafts of the manuscript. MET contributed to the conceptualization, funding acquisition, and writing for the review and editing drafts. CD contributed to the conceptualization and writing of the review and editing drafts. MSA contributed to the conceptualization, supervision, funding acquisition, and writing of the review and editing drafts. All authors have read and approved the final version of the manuscript and agree to be accountable for the work.